Direxion Daily Pharmaceutical & Medical Bull 3X Shares Rating $7.85 -0.12 (-1.51%) Closing price 04:10 PM EasternExtended Trading$7.83 -0.02 (-0.20%) As of 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily Pharmaceutical & Medical Bull 3X Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy 2.70Holdings in PILL have an aggregate rating of Moderate Buy based on 231 analyst ratings issued in the past year covering 21 companies (47.6% of the portfolio).PILL Aggregate Price Target$7.85High Prediction$7.85Average Prediction$7.85Low Prediction$7.85Holdings in PILL have an aggregate price target of $7.85 and a range of $7.85 to $7.85 covering 21 companies (47.6% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 PILL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.17%TARSTarsus Pharmaceuticals$54.33-3.8%2.4881 of 5 stars2.71$66.67 22.7%7Positive NewsInsider Trade2.75%ELANElanco Animal Health$18.35-2.2%2.728 of 5 stars2.78$17.33 -5.5%92.69%JAZZJazz Pharmaceuticals$126.90-1.3%4.4947 of 5 stars2.88$178.67 40.8%16Positive News2.65%VTRSViatris$10.24-2.0%1.721 of 5 stars1.80$10.40 1.6%52.59%JNJJohnson & Johnson$175.70-0.7%4.6474 of 5 stars2.65$176.29 0.3%20Trending NewsAnalyst Revision2.55%AXSMAxsome Therapeutics$124.12-1.2%4.7488 of 5 stars3.13$177.86 43.3%15Positive NewsInsider Trade2.43%RPRXRoyalty Pharma$36.18-0.9%4.9821 of 5 stars3.33$48.00 32.7%3News CoveragePositive News2.37%MRKMerck & Co., Inc.$84.06-0.7%4.9963 of 5 stars2.35$107.44 27.8%20Positive News2.29%PFEPfizer$24.59-0.5%4.9003 of 5 stars2.39$28.12 14.4%18Trending News2.26%CORTCorcept Therapeutics$71.62-0.2%4.8547 of 5 stars3.00$135.25 88.8%5News CoverageAnalyst Forecast2.20%OGNOrganon & Co.$10.26-1.0%4.6361 of 5 stars2.80$17.33 68.9%5Positive News2.14%BMYBristol Myers Squibb$47.15-0.2%4.8934 of 5 stars2.24$56.38 19.6%21News CoveragePositive News2.07%ZTSZoetis$149.45-0.2%4.8679 of 5 stars2.56$200.88 34.4%9News CoveragePositive NewsAnalyst Forecast2.07%ANIPANI Pharmaceuticals$97.46-1.0%3.9177 of 5 stars3.10$88.25 -9.5%10Analyst Forecast2.06%LLYEli Lilly and Company$754.24+0.5%5 of 5 stars2.70$950.17 26.0%23Trending News2.02%LQDALiquidia Technologies$27.29-1.8%3.495 of 5 stars3.00$32.11 17.7%101.94%HRMYHarmony Biosciences$33.21-2.3%4.5382 of 5 stars3.00$51.00 53.6%10Positive News1.93%XERSXeris Biopharma$7.81+1.7%3.4274 of 5 stars2.83$7.08 -9.3%6Positive NewsShort Interest ↓1.93%PRGOPerrigo$22.11-0.8%4.9552 of 5 stars2.40$33.00 49.3%5Positive News1.78%PBHPrestige Consumer Healthcare$65.03-1.5%4.5927 of 5 stars2.29$93.33 43.5%7Positive News1.75%PCRXPacira BioSciences$26.61+1.2%3.2477 of 5 stars2.71$30.83 15.9%7Positive News This page (NYSEARCA:PILL) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Pharmaceutical & Medical Bull 3X Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PILL Stock Alerts